timolol
Generic: TIMOLOL MALEATE·Brand: BETIMOL, BLOCADREN, Betimol, Combigan, Cosopt, ISTALOL, Istalol, TIMOLOL, TIMOLOL MALEATE, TIMOPTIC, TIMOPTIC IN OCUDOSE, TIMOPTIC-XE, Timoptic
timolol: 1 clinical trial tracked.
timolol evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about timolol, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
Clinical Trial Registry Records (1)
A Phase 2, Open-Label, Randomized Trial Evaluating the Impact of Enhanced Versus Standard Dermatologic Management on Selected Dermatologic Adverse Events Among Patients With Locally Advanced or Metastatic EGFR-Mutated NSCLC Treated First-Line With Amivantamab + Lazertinib
Primary endpoint: Number of Participants With Grade Greater Than or Equal to (>=) 2 Dermatologic Adverse Events of Interest (DAEIs) Within 12 Weeks After Initiation of Anticancer Treatment
InterventionalRandomizedopen305 enrolledStarted 2024-02Completion 2030-0650 sites · Argentina, Brazil, China, United StatesJanssen Research & Development, LLC